Developing a new drug or pharmaceutical product for the market can be a tortuous process. From the earliest pre-clinical trials to final marketing approvals, a rigorous set of criteria must be met if a product is to proceed to the point at which it can be approved for the treatment of patients.
This FDA slideshow provides a framework for pharmaceutical companies to improve quality and help pass increasingly stringent regulatory standards.
Nenhum comentário:
Postar um comentário